These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7212688)

  • 21. Peritoneal resorption capacity for the inflammatory mediators in acute experimental Staphylococcus aureus peritonitis.
    Torab FC; Abu-Zidan FM; Al-Salam S; Berger D; Branicki FJ
    Ulus Travma Acil Cerrahi Derg; 2009 Jul; 15(4):330-6. PubMed ID: 19669960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Selection of an optimal kanamycin treatment plan in experimental peritonitis in rats].
    Bodunkova LE; Fishman VM; Fomina IP; Navashin SM
    Antibiotiki; 1972 Nov; 17(11):986-91. PubMed ID: 4664268
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pharmacokinetic interpretation of the myorelaxant effect of kanamycin].
    Firsov AA; Solov'ev VN
    Antibiotiki; 1980 May; 25(5):349-52. PubMed ID: 7387129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D; Koomen GC; Hart AA; ten Berge IJ; Struijk DG; Krediet RT
    J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concomitant increase in neutrophil adhesion to inflammatory peritoneum and remote organs during peritonitis.
    Fukatsu K; Saito H; Han I; Inoue T; Furukawa S; Matsuda T; Ikeda S; Yasuhara H; Muto T
    J Surg Res; 1999 Feb; 81(2):156-63. PubMed ID: 9927534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of proteolytic enzymes in the pathogenesis of the toxic syndrome in peritonitis].
    Sinovets AA; Zubkov OB; Dzizenko SN; Levitskiĭ AP; Vovchuk SV
    Vestn Khir Im I I Grek; 1985 Jan; 134(1):71-3. PubMed ID: 3887738
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of experimental peritonitis and ischaemia on peritoneal fibrinolytic activity.
    Vipond MN; Whawell SA; Thompson JN; Dudley HA
    Eur J Surg; 1994 Sep; 160(9):471-7. PubMed ID: 7849165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
    Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
    Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peritoneal effects of intravenous iron sucrose administration in rats.
    Breborowicz A; Polubinska A; Breborowicz M; Simon M; Wanic-Kossowska M; Oreopoulos DG
    Transl Res; 2007 Jun; 149(6):304-9. PubMed ID: 17543848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Kanamycin sulfate and sodium cephazolin pharmacokinetics in experimental strangulation obstruction of the small intestine].
    Eriukhin IA; Poliak MS; Rukhliada NV
    Vestn Khir Im I I Grek; 1981 Jul; 127(7):21-6. PubMed ID: 7292844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the absorption, excretion and metabolism of dimethylsulfoxide (DMSO) in man.
    Hucker HB; Miller JK; Hochberg A; Brobyn RD; Riordan FH; Calesnick B
    J Pharmacol Exp Ther; 1967 Feb; 155(2):309-17. PubMed ID: 6025521
    [No Abstract]   [Full Text] [Related]  

  • 32. Enhanced local production of vascular endothelial growth factor is not sufficient to increase peritoneal permeability to protein during acute peritonitis.
    Leypoldt JK; Kamerath CD; Gilson JF
    Transl Res; 2007 Aug; 150(2):130-7. PubMed ID: 17656333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraperitoneal kanamycin.
    COHN I; COTLAR AM
    Ann Surg; 1962 Apr; 155(4):532-7. PubMed ID: 13880353
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of peritonitis on oxygen consumption by various tissues and peritoneal fluid cells.
    Renvall S; Niinikoski J
    Acta Chir Scand; 1980; 146(7):493-9. PubMed ID: 7223286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyridoxal phosphate and hepatocyte growth factor prevent dialysate-induced peritoneal damage.
    Nakamura S; Niwa T
    J Am Soc Nephrol; 2005 Jan; 16(1):144-50. PubMed ID: 15563557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comprehensive treatment of acute hematogenic osteomyelitis in newborn and young infants by using dimexide and HBO therapy].
    Borovik PI
    Vestn Khir Im I I Grek; 1980 Feb; 124(2):135-8. PubMed ID: 7368490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peritoneal absorption of the antibacterial and antiendotoxin taurolin in peritonitis.
    Knight BI; Skellern GG; Browne MK; Pfirrmann RW
    Br J Clin Pharmacol; 1981 Nov; 12(5):695-9. PubMed ID: 7332737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of transdiaphragmatic lymphatic absorption reduced systemic inflammatory response syndrome during experimental peritonitis: evaluation with body oxygen kinetics in rats.
    Gürleyik E; Gürleyik G; Unalmişer S
    Eur J Surg; 1996 Sep; 162(9):729-34. PubMed ID: 8908455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intra-abdominal administration of dimexide solutions (DMSO) in the complex treatment of purulent peritonitis].
    Zverev VM
    Vrach Delo; 1978 Jan; (1):59-61. PubMed ID: 625946
    [No Abstract]   [Full Text] [Related]  

  • 40. [The influence of dimethylsulfoxide on the absorption of phenylbutazone].
    Pantio M; Kärki NT
    Arch Interam Rheumatol; 1965 Sep; 8(3):133-47. PubMed ID: 5176257
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.